Skip to content
EndoVia Therapeutics
PlatformUse CasesProgramsNewsAboutFAQDiscuss a project

EndoVia / Legal information

Terms of use

Rules for using the website and email enquiries.

On this page

1. Provider and scope2. Information and research content3. Email enquiries and correspondence4. Permitted use and intellectual property5. Availability, external links and liability6. Privacy7. Law, disputes and updates

1. Provider and scope

The website is operated by EndoVia Therapeutics d.o.o., Ulica škofa Maksimilijana Držečnika 6, 2000 Maribor, Slovenia; registration number 9944389000; VAT ID SI75836688; registered with the Slovenian Business Register (AJPES). Contact: info@endovia.eu.

These terms govern the information website and email enquiries. Individual research collaborations, purchases or investments require separate agreements.

Last updated: 19 October 2026. Domain: www.endovia.eu.

2. Information and research content

Content describes the company, scientific foundations and development activities. It is not medical advice, diagnosis, a treatment recommendation, a promise of clinical outcomes or confirmation of regulatory approval. Consult an appropriately qualified health professional about medical questions.

Publications, patents and funding information have their own context and limitations. A planned capability is not necessarily achieved or available. Content is not a public securities offering or personal investment recommendation.

3. Email enquiries and correspondence

Provide accurate contact details and only information you are entitled to share. Do not send medical records, sensitive personal data, trade secrets or confidential research material. First agree on a suitable channel and confidentiality terms for such exchanges.

An enquiry does not create a contract, guarantee project acceptance or establish a confidentiality agreement. Any collaboration is agreed separately.

Contact us by email at info@endovia.eu.

4. Permitted use and intellectual property

EndoVia Therapeutics® is a registered trademark of EndoVia Therapeutics d.o.o. in the European Union (EUTM No 019371133).

Use the site lawfully, without compromising its security, operation or others’ rights. Abuse, spam, malicious code and unauthorized access attempts are prohibited.

Texts, logos, photographs and other elements are protected where legal protection applies and belong to EndoVia or their respective rights holders. Viewing and use within statutory exceptions are permitted; other reproduction or commercial use requires permission. Third-party content is also subject to its licenses.

Sending an enquiry does not transfer ownership of your research or intellectual property. We use its content to handle your message.

5. Availability, external links and liability

We aim for accurate content and reliable operation, but errors, changes and interruptions may occur. Please report errors you notice. External links provide additional sources; we do not control their content or availability.

Mandatory law governs liability. These terms do not exclude or limit liability where prohibited by law, including for intent or gross negligence, or restrict non-waivable individual or consumer rights. Assess content in light of its informational and research purpose.

6. Privacy

Personal data processing is explained in the Privacy policy. Accepting these terms does not waive GDPR rights or replace separate consent where required.

7. Law, disputes and updates

Slovenian law and directly applicable EU law apply. This does not reduce protection under otherwise applicable mandatory rules, including jurisdiction rules. Courts are determined by applicable law; no exclusive jurisdiction is imposed to a consumer’s detriment.

Send questions or concerns first to info@endovia.eu. We may update these terms for future use, publishing the new version date without retroactive effect. Material changes requiring fresh acceptance will be presented for that purpose.

InvestEU support

This operation benefits from support from the European Union under the InvestEU Fund

Vesna Venture CapitalEuropean UnionEuropean Investment FundSID BankaHBOR
Funded by the European Union

PRECISION-ECS is funded by the European Union under Horizon Europe grant agreement No 101310106.

Explore PRECISION-ECS →

Mechanistic precision oncology. Helping drug developers understand who responds to treatment, and why.

Explore

PlatformUse CasesProgramsNewsAboutFAQContact

Connect

info@endovia.eu

Maribor, Slovenia

LinkedIn ↗
EndoVia Therapeutics

© 2026 EndoVia Therapeutics d.o.o.

Privacy policyTerms of use

EndoVia Therapeutics is a registered trademark of EndoVia Therapeutics d.o.o. in the European Union (EUTM No 019371133).

Research and development stage. This website does not provide medical advice or individual treatment recommendations.